NF-κB activation in organs from STZ-treated rats

Applied Physiology, Nutrition and Metabolism

Volumn 36, Issue 1, 2011, Pages 121-127

  Locke, Marius ^a   Anderson, Jocelyn ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes; Heart; NF B; Remodeling; STZ; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL DIABETES MELLITUS; GEL MOBILITY SHIFT ASSAY; GENETICS; MALE; METABOLISM; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MALE; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

EID: 79954508354     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/H10-094     Document Type: Article

References (26)

1. Auwardt, R., Mudge, S., and Power, D. 2000. Transcription factor NF-κB in glomerulonephritis. Nephrology, 5(1-2): 71-82. doi:10.1046/j.1440-1797.2000.00518.x.
2. Bakkar, N., Wang, J., Ladner, K.J., Wang, H., Dahlman, J.M., Carathers, M., et al. 2008. IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180(4): 787-802. doi:10.1083/jcb.200707179. PMID:18299349.
3. Baldwin, A. 1996. The NF-κB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14(1): 649-683. doi:10. 1146/annurev.immunol.14.1.649. PMID:8717528.
4. Bar-Shai, M., Carmeli, E., Ljubuncic, P., and Reznick, A.Z. 2008. Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-κB activation. Free Radic. Biol. Med. 44(2): 202-214. doi:10.1016/j.freeradbiomed.2007.03.019. PMID:18191756.
5. Bidani, A.K., Picken, M., Hacioglu, R., Williamson, G., and Griffin, K.A. 2007. Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am. J. Physiol. Renal Physiol. 292(2): F647-F654. doi:10.1152/ajprenal.00017.2006. PMID:16968892.
6. Brigelius-Flohé, R., Bilgin, B., Eickemeier, S., Hipskind, R., Singh, M., Szamel, M., and Resch, K. 1996. The NF-κB heterodimer/ homodimer balance and IL-1 stimulated IL-2 production in murine T lymphocytes. Biofactors, 5(4): 169-174. PMID:9084874.
7. Cai, D., Frantz, J.D., Tawa, N.E., Jr., Melendez, P.A., Oh, B.C., Lidov, H.G., et al. 2004. IKKb/NF-κB activation causes severe muscle wasting in mice. Cell, 119(2): 285-298. doi:10.1016/j.cell.2004.09.027. PMID:15479644.
8. Cam, M.C., Rodrigues, B., and McNeill, J.H. 1999. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur. J. Endocrinol. 141(5): 546-554. doi:10.1530/eje.0.1410546. PMID:10576774.
9. Frier, B.C., Noble, E.G., and Locke, M. 2008. Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-κB activation and expression. Cell Stress Chaperones, 13(3): 287-296. doi:10.1007/s12192-008-0062-0. PMID:18633731.
10. Gilmore, T.D. 2006. Introduction to NF-κB: players, pathways, perspectives. Oncogene, 25(51): 6680-6684. doi:10.1038/sj.onc. 1209954. PMID:17072321.
11. Granic, I., Dolga, A.M., Nijholt, I.M., van Dijk, G., and Eisel, U.L. 2009. Inflammation and NF-κB in Alzheimer's disease and diabetes. J. Alzheimers Dis. 16(4): 809-821. PMID:19387114.
12. Grimm, S., and Baeuerle, P.A. 1993. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290(Pt. 2): 297-308. PMID:8452515.
13. Grundström, S., Anderson, P., Scheipers, P., and Sundstedt, A. 2004. Bcl-3 and NFkB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells. J. Biol. Chem. 279(9): 8460-8468. doi:10.1074/jbc.M312398200. PMID:14668329.
14. Hall, G., Hasday, J.D., and Rogers, T.B. 2006. Regulating the regulator: NF-κB signaling in heart. J. Mol. Cell. Cardiol. 41(4): 580-591. doi:10.1016/j.yjmcc.2006.07.006. PMID:16949095.
15. Hunter, R.B., Stevenson, E., Koncarevic, A., Mitchell-Felton, H., Essig, D.A., and Kandarian, S.C. 2002. Activation of an alternative NF-κB pathway in skeletal muscle during disuse atrophy. FASEB J. 16(6): 529-538. doi:10.1096/fj.01-0866com. PMID:11919155.
16. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259): 680-685. doi:10.1038/227680a0. PMID:5432063.
17. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1): 265-275. PMID:14907713.
18. Mabley, J.G., Haskó, G., Liaudet, L., Soriano, F.G., Southan, G.J., Salzman, A.L., and Szabo, C. 2002. NFkB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. Endocrinology, 173(3): 457-464. doi:10.1677/joe.0. 1730457. PMID:12065235.
19. Mezzano, S., Aros, C., Droguett, A., Burgos, M.E., Ardiles, L., Flores, C., et al. 2004. NF-κB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transplant. 19(10): 2505-2512. doi:10.1093/ndt/gfh207. PMID:15280531.
20. Senftleben, U., Cao, Y., Xiao, G., Greten, F.R., Krähn, G., Bonizzi, G., et al. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-κB signaling pathway. Science, 293(5534): 1495-1499. doi:10.1126/science.1062677. PMID:11520989.
21. Snell-Bergeon, J.K., West, N.A., Mayer-Davis, E.J., Liese, A.D., Marcovina, S.M., D'Agostino, R.B., Jr., et al. 2010. Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study. J. Clin. Endocrinol. Metab. 95(6): 2868-2876. doi:10.1210/jc.2009-1993. PMID:20371668.
22. Tesch, G.H., and Allen, T.J. 2007. Rodent models of streptozotocininduced diabetic nephropathy. Nephrology (Carlton), 12(3): 261-266. doi:10.1111/j.1440-1797.2007.00796.x. PMID:17498121.
23. Thomas, M.C., and Atkins, R.C. 2006. Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs, 66(17): 2213-2234. doi:10.2165/00003495-200666170-00005. PMID:17137404.
24. Timmers, L., van Keulen, J.K., Hoefer, I.E., Meijs, M.F., van Middelaar, B., den Ouden, K., et al. 2009. Targeted deletion of nuclear factor kB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ. Res. 104(5): 699-706. doi:10.1161/CIRCRESAHA.108.189746. PMID:19168865.
25. Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76(9): 4350-4354. doi:10.1073/pnas.76.9.4350. PMID:388439.
26. Werner, S.L., Barken, D., and Hoffmann, A. 2005. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science, 309(5742): 1857-1861. doi:10. 1126/science.1113319. PMID:16166517.